Keating Investment Counselors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-635
Closed -$232K 83
2022
Q4
$232K Buy
+635
New +$225K 0.09% 76

Other funds holding LLY

Keating Investment Counselors's LLY Position: Q1 2023 in Review

Keating Investment Counselors sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 635 shares — an estimated $232K sold.

Keating Investment Counselors first reported a position in LLY in Q4 2022 and held it in 1 quarter. The position peaked at $232K in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Keating Investment Counselors reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Keating Investment Counselors sold 635 Eli Lilly shares in Q1 2023, an estimated $232K.
  • Keating Investment Counselors first reported a position in Eli Lilly in Q4 2022 and held it in 1 quarter.
  • Keating Investment Counselors's Eli Lilly position peaked at $232K in Q4 2022.
  • 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Keating Investment Counselors's 13F filing for Q1 2023, filed 4 May 2023.